Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.
Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.
The NCI has launched an initiative to identify genetic alterations that create susceptibility to prostate and breast cancer. The three-year, $14 million Cancer Genetic Markers of Susceptibility project will begin by scanning 2500 genetic samples from men who have been diagnosed with prostate cancer as well as a control group. Data will be available via the NCI.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.